Oral MES supplementation improved diet-induced obesity and metabolic syndrome partially by elevating signals associated with lipid catabolism, including lipolysis, mitochondrial biogenesis, and the number of UCP1-positive cells in adipose tissues14. The gene discussed is UCP1; the disease is obesity disorder.